First Trust Advisors LP Cytek Biosciences, Inc. Transaction History
First Trust Advisors LP
- $101 Billion
- Q3 2024
A detailed history of First Trust Advisors LP transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 76,810 shares of CTKB stock, worth $463,164. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76,810
Previous 60,164
27.67%
Holding current value
$463,164
Previous $335,000
26.87%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CTKB
# of Institutions
135Shares Held
72.2MCall Options Held
400Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$71 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD9.49MShares$57.2 Million1.15% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$40.1 Million0.85% of portfolio
-
State Street Corp Boston, MA4.17MShares$25.1 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $812M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...